Taking IBRANCE: CA15-3 up, SUV down. What does it mean?

txd
txd Member Posts: 10

Hi everyone, this is my first post in this community and I'm posting to help my mother. We just found out a few months ago that after 15 years of being 'cured', she has a metastasized tumor in her bone with no primary tumor in her breast. She was diagnosed ER-Positive HER-2 Negative 15 years ago (but we are concerned this may have changed). She has one bone tumor now and we're very lucky to have detected it when there was only one. Her CA 15-3 jumped from 25 to 30 (and she also had random fevers), and thankfully our oncologist allowed her to do a PET-CT, from which we found that she had a 1.3cm tumor in her left sacrum with SUV activity of 9.6. She didn't have any pains (again, thankful) and still doesn't.

Her oncologist started her on Ibrance/Femera/Zomeda. In 3 months, she did a PET-CT and her SUV went down to 2.9. This is good and we're very happy. However, what really concerns me is that her CA15-3 did not go down. It's been slowly increasing over the last 5 months (from 30 to 43 over 6 months). I read that sometimes after you start medication, that value might jump up, but it should start becoming meaningful after a month or so, especially its trend over time. I also read that when Ibrance works, people's CA 15-3 numbers do come down. I'm so worried that this means microscopically her tumor is spreading and PET-CT is just not detecting that spread. I feel really helpless because there's not much we can do. The position of her tumor makes it hard for a needle biopsy. My mom really doesn't want to do open surgery. Bone biopsies are complicated since they need to treat the bone. I fear that her tumor type changed and we're not giving her the right treatment. If her SUV value came down, why would the tumor marker not? Also her CA27-29 also shot up from 22.9 (a year ago) to 38.9 (now).

Does anyone else have any experience/know anyone with experience of people taking Ibrance for HER-negative but their tumor marker not coming down but SUV coming down? What does this mean and at least, in your experiences, what has that led to? I rather know what is likely to happen than just hope it doesn't mean anything. Kind of here looking for the truth to best prepare for the future. For example, if this means it's only a matter of time before those marker values translate to tumors, we should perhaps focus the next year on traveling and spending time together while she feels good enough to travel (that is more or less her dream). I was devastated when I first found out about the tumor but now I feel I am strong and want to make the most of my time with my mother. Thank you everyone!



Comments

  • zarovka
    zarovka Member Posts: 3,607
    edited July 2017

    I am on Ibrance. Here is my CA15-3 and my CA 27.29 since diagnosis and starting Ibrance mid February. Scans suggest tumor load decreased in February-March 2016 and again in early 2017. Make what you will of the ups and downs ... I think the increases correlate with the REDUCTION in my tumor load .... but many doctors do not monitor TM's and other don't respond to them until the see 5X to 10X changes.

    I like data so I keep monitoring TM's. I've learned a few things. But I honestly think that most of the time the main thing TM's accomplish is to make people worry to no real benefit.

    >Z<


    image

    image

  • txd
    txd Member Posts: 10
    edited July 2017

    Wow Zarovka thanks so much for your input! I really appreciate this. You seem like you had a huge drop 12/2016 to 1/2017. Any idea for what happened that month? Did you also feel different during that time? For example, less discomfort or side effects?

  • zarovka
    zarovka Member Posts: 3,607
    edited July 2017

    No clue what happened that month. What the variability of my markers shows me is that ... I agree with doctors that you need a 2X to 10X change to really have a "change".

    I've been reading more today about biomarkers for MBC. At least one small study showed that CA 15-3 is not predictive at all in women, like me, with levels of the antigen is below 50 U/ml. In their study it was reasonably predictive when the levels get above 50 U/ml. This roughly correlates with what I see reading people's experience on this forum.

    This observation is an incidental finding in this paper which is otherwise about cfDNA as a biomarker.

    Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

    I have created a thread on biomarkers of MBC, how much they suck and what better options we may have coming.

    cfDNA and monitoring response to MBC treatment

    Pardon my French, but it is late and I am very very tired of cancer.

    >Z<

  • vrtameshrew48
    vrtameshrew48 Member Posts: 7
    edited August 2017

    I'M GOING CRAZY. Just got diagnosed with mets to the liver in May. I started ibrance and letrozole, but haven't been on them very long. Having problems with kidneys and white cell counts. Doctor changed Ibrance from 125 to 100 and that seems to help, but I just took a Ca-15-3 tumor marker test and it went from 48 to 58. I had a scan that showed the liver tumor first grew, then shrunk--but now another scan shows "indeterminate" concerning areas in other places in the liver...Does Ibrance work or not?

  • ABeautifulSunset
    ABeautifulSunset Member Posts: 990
    edited August 2017

    Ibrance works for some, but not forothers. Like every other BC treatment, it's a crap shoot. Also, I don't know too many people who have been on it effectively for more than a year or two. I was on it for two years. It took almost four months for it to start working. Then it only worked for a year. My TMs went up slowly over the next 10 months, and I eventuallyhad progressionto my liver (seen this theme in a few of us here). Now I'm on Xeloda.

    But it's totally worth a shot. Just don't wait too long if your markers are climbing.

  • txd
    txd Member Posts: 10
    edited November 2017

Categories